Enhertz IV infusion 100mg contains trastuzumab deruxtecan (genetical recombination) and is manufactured by Daiichi Sankyo. This injectable drug (YJ code: 4291452D1029) is supplied as 100mg per bottle, indicated for the treatment of unresectable or metastatic HER2-positive breast cancer and gastric cancer.
Enhertz IV infusion 100mg
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).